I came home for a flash drive and found my fiancé on one knee in my parents’ living room, holding out a diamond ring to the sister who had spent twenty years being given everything I was told I was strong enough to live without.
Chapter 2
Eighteen months earlier, Dr. Margaret Shaw from the National Biomedical Research Institute had contacted me after reading a technical paper I had presented at a wound-care symposium in Chicago. She was assembling a federally funded team to develop a new regenerative treatment for severe burns and chronic wounds, and she wanted me to lead the technical program.
The position required security clearance, relocation to Maryland and strict confidentiality during the transition. It also offered something I had almost forgotten professional life could include.
A salary.
Authority.
Credit for my own work.
At Bennett Biotherapeutics, Dad had called me a “family technical adviser.” The arrangement began informally when I finished my doctorate and became permanent because nobody saw a reason to change it. I already had consulting income and research grants, he said. Someday, when Bennett Biotherapeutics became valuable, we would all benefit.
I believed him longer than I should have.
Two years into my work there, I sent Dad an email asking for a formal intellectual-property assignment agreement. By then, several inventions I had personally developed were becoming central to the company’s valuation.
His reply consisted of two sentences.
Emily, we’re family. Let’s not make this complicated.
No agreement was ever prepared.
So I continued doing what scientists are trained to do.
I documented everything.
Every experiment had a date. Every draft carried metadata. Every patent concept included an authorship record. My research notebooks were witnessed. My source files were archived.
At the time, I thought I was merely being careful.
I had no idea I was building the evidence that would eventually save my career.
Dr. Shaw gave me months to decide. Once I accepted, we arranged my departure quietly. My family believed I was considering a year-long research sabbatical in Europe. Ethan believed it too.
I had planned to tell him after the October wedding.
That seems foolish now, but at the time I still believed marriage meant becoming a team.
The night I found him proposing to Lily, the federal car took me directly to a temporary apartment outside Bethesda.
My phone buzzed for most of the drive.
Mom called seven times.
Dad called four.
Lily sent a long message beginning with, I hope someday you’ll understand.
Ethan’s message was shorter.
You’re upset, but don’t do something irrational. Your entire professional network is tied to this family.
An hour later another arrived.
You have nowhere to go if you burn this bridge.
I read that one twice.
Then I turned off the phone.
Monday morning, I reported to the institute with my credentials and the black flash drive.
Dr. Shaw met me at security.
“I heard there were complications,” she said.
“That’s one word for them.”
She studied my face, but she did not pry.
“Ready to work?”
“Yes.”
“Good.”
And that was how my old life ended.
Not with screaming.
Not with revenge.
With an ID badge, a laboratory coat and a door that opened when I pressed my own credentials against the scanner.
For three months, I heard almost nothing from home.
Then our legal office asked me to attend a meeting.
An intellectual-property attorney named Sandra Morales placed four patent applications on the conference table.
“Bennett Biotherapeutics filed these six weeks ago,” she said. “Are you familiar with the subject matter?”
I opened the first document.
My stomach tightened.
The application described modifications to the wound-film platform I had designed over the previous two years.
Or rather, it tried to describe them.
Parameter definitions contradicted each other. Experimental claims were unsupported. Several figures had been copied from preliminary reports without the accompanying limitations.
“Who wrote this?” I asked.
Sandra slid over the signature page.
Lily Bennett.
Technical Development Director.
For several seconds, I could only stare.
My sister had completed nursing school the previous year. She was intelligent and charming, and she understood enough medical vocabulary to impress people who were not specialists.
She was not a biomedical engineer.
She could not design these experiments.
She could not validate these claims.
And she certainly could not explain why a particular polymer concentration behaved differently in living tissue than it did in a laboratory dish.
The U.S. Patent and Trademark Office had already challenged the applications. Bennett Biotherapeutics responded by hiring outside counsel, which created a larger problem.
The law firm reviewed the source files and found the same name embedded throughout the original material.
E. Prior-Bennett.
Mine.
Prior was my birth surname, which I had begun using professionally in my twenties. My family rarely noticed anything that did not require their immediate attention, so none of them ever asked why journal articles listed me that way.
Outside counsel did.
They asked Bennett Biotherapeutics to produce the document transferring E. Prior-Bennett’s intellectual property to the corporation.
No such document existed.
That was when Ethan started looking for me.
He called my former university department. He called two hospitals where I had consulted. He called colleagues.
Nobody gave him anything.
My institute position was not publicly listed during the early program phase. When inquiries reached federal offices, the response was simple.
Employment information restricted.
I heard later that Jason finally figured it out. He remembered me mentioning Dr. Shaw years earlier and found her name in a federal budget report about regenerative medicine.
He called Ethan.
Ethan called Dad.
Then somebody finally opened the intellectual-property audit Ethan’s investment firm had conducted before putting millions into Bennett Biotherapeutics.
Eleven of the company’s fourteen core research assets named me as originating inventor or principal technical author.
Eleven.
Ethan asked Dad whether I had ever signed those rights away.
Dad apparently stared at the papers for nearly a minute.
“No,” he admitted.
By then, losing the patents was no longer their worst problem.
Because Lily had found another folder.
And this time, people had been hurt.
